Cysticercosis differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
Ahmed Younes (talk | contribs) No edit summary |
Ahmed Younes (talk | contribs) No edit summary |
||
Line 24: | Line 24: | ||
* [[Immunoblot|CDC's immunoblot]] is based on detection of [[antibody]] to one or more of [[Glycoprotein|7 lentil-lectin purified structural glycoprotein]] [[antigens]] from the larval cysts. | * [[Immunoblot|CDC's immunoblot]] is based on detection of [[antibody]] to one or more of [[Glycoprotein|7 lentil-lectin purified structural glycoprotein]] [[antigens]] from the larval cysts. | ||
* It is 100% [[Specificity (tests)|specific]] and has a [[sensitivity]] superior to that of any other test yet evaluated | * It is 100% [[Specificity (tests)|specific]] and has a [[sensitivity]] superior to that of any other test yet evaluated | ||
|[[Computed tomography|Computerized tomography (CT)]] is superior to [[magnetic resonance imaging|magnetic resonance imaging (MRI)]] for demonstrating small [[calcification]]s. However, [[MRI]] shows [[cysts]] in some locations (cerebral convexity, [[Ependyma|ventricular ependyma]]) better than [[CT]], is more [[Sensitivity|sensitive]] than CT to demonstrate surrounding [[cerebral edema|edema]], and may show internal changes indicating the death of cysticerci. | | | ||
* [[Computed tomography|Computerized tomography (CT)]] is superior to [[magnetic resonance imaging|magnetic resonance imaging (MRI)]] for demonstrating small [[calcification]]s. | |||
* However, [[MRI]] shows [[cysts]] in some locations (cerebral convexity, [[Ependyma|ventricular ependyma]]) better than [[CT]], is more [[Sensitivity|sensitive]] than CT to demonstrate surrounding [[cerebral edema|edema]], and may show internal changes indicating the death of cysticerci. | |||
|- | |- | ||
|[[Brain abscess]] | |[[Brain abscess]] | ||
Line 60: | Line 62: | ||
# Signs of [[increased intracranial pressure]] | # Signs of [[increased intracranial pressure]] | ||
# [[Focal neurologic signs|Focal neurologic deficits]]. | # [[Focal neurologic signs|Focal neurologic deficits]]. | ||
|[[TB|T.B.]] should be investigated everywhere else in the body (e.g. [[Lymphadenopathy|peripheral lymphadenopathy]], [[Sputum culture|sputum]] and [[blood culture]]) | | | ||
* [[TB|T.B.]] should be investigated everywhere else in the body (e.g. [[Lymphadenopathy|peripheral lymphadenopathy]], [[Sputum culture|sputum]] and [[blood culture]]) | |||
| | | | ||
* [[CT]]: [[Contrast enhanced CT|Contrast-enhanced CT]] scan shows a ring enhancing lesion surrounded by an area of hypodensity ([[cerebritis]]) and the resulting [[mass effect]]. | * [[CT]]: [[Contrast enhanced CT|Contrast-enhanced CT]] scan shows a ring enhancing lesion surrounded by an area of hypodensity ([[cerebritis]]) and the resulting [[mass effect]]. | ||
Line 66: | Line 69: | ||
|- | |- | ||
|Neurosarcoidosis | |Neurosarcoidosis | ||
|70% of the patients present with the neurological symptoms rather than the presentation of systemic disease. Common presentations are:<ref name="urlNeurosarcoidosis">{{cite web |url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975794/ |title=Neurosarcoidosis |format= |work= |accessdate=}}</ref> | | | ||
* 70% of the patients present with the neurological symptoms rather than the presentation of systemic disease. Common presentations are:<ref name="urlNeurosarcoidosis">{{cite web |url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975794/ |title=Neurosarcoidosis |format= |work= |accessdate=}}</ref> | |||
# Cranial nerve neuropathies: [[Facial palsy]] is the most common presentation. | # Cranial nerve neuropathies: [[Facial palsy]] is the most common presentation. | ||
# [[Meningeal]] involvement: diffuse [[Meningitis|meningeal inflammation]] can cause diffuse [[Polyneuropathy|basilar polyneuropathy]] in 40% of the patients. with [[neurosarcoidosis]]. | # [[Meningeal]] involvement: diffuse [[Meningitis|meningeal inflammation]] can cause diffuse [[Polyneuropathy|basilar polyneuropathy]] in 40% of the patients. with [[neurosarcoidosis]]. | ||
Line 80: | Line 83: | ||
* [[Lumbar puncture]] shows elevated [[CSF]] proteins together with mild-moderate [[pleocytosis]]. It is usually accompanied by [[oligoclonal bands]].<ref name="urlNeurosarcoidosis">{{cite web |url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975794/ |title=Neurosarcoidosis |format= |work= |accessdate=}}</ref> | * [[Lumbar puncture]] shows elevated [[CSF]] proteins together with mild-moderate [[pleocytosis]]. It is usually accompanied by [[oligoclonal bands]].<ref name="urlNeurosarcoidosis">{{cite web |url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975794/ |title=Neurosarcoidosis |format= |work= |accessdate=}}</ref> | ||
|[[Magnetic resonance imaging|MRI]] with [[contrast]] shows enhancement of the inflamed areas (i.e. [[cranial nerves]], [[meninges]] or [[Hypothalamic pituitary adrenal axis|HPO axis]]) | | | ||
* [[Magnetic resonance imaging|MRI]] with [[contrast]] shows enhancement of the inflamed areas (i.e. [[cranial nerves]], [[meninges]] or [[Hypothalamic pituitary adrenal axis|HPO axis]]) | |||
|} | |} | ||
{| class="wikitable" | {| class="wikitable" | ||
Line 121: | Line 125: | ||
|- | |- | ||
|Hyperthyroid Ophthalmopathy | |Hyperthyroid Ophthalmopathy | ||
|The hallmark is [[Exophthalmos|Eye protrusion]], [[photophobia]], [[lacrimation]] and later in the disease, diminished eye motility.<ref name="urlThyroid Ophthalmopathy - EyeWiki">{{cite web |url=http://eyewiki.aao.org/Thyroid_Ophthalmopathy |title=Thyroid Ophthalmopathy - EyeWiki |format= |work= |accessdate=}}</ref> | | | ||
* The hallmark is [[Exophthalmos|Eye protrusion]], [[photophobia]], [[lacrimation]] and later in the disease, diminished eye motility.<ref name="urlThyroid Ophthalmopathy - EyeWiki">{{cite web |url=http://eyewiki.aao.org/Thyroid_Ophthalmopathy |title=Thyroid Ophthalmopathy - EyeWiki |format= |work= |accessdate=}}</ref> | |||
| | | | ||
* [[Ultrasonography]]: inflamed thickened [[extraocular muscles]]. | * [[Ultrasonography]]: inflamed thickened [[extraocular muscles]]. |
Revision as of 14:08, 31 July 2017
Cysticercosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Cysticercosis differential diagnosis On the Web |
American Roentgen Ray Society Images of Cysticercosis differential diagnosis |
Risk calculators and risk factors for Cysticercosis differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Ahmed Younes M.B.B.CH [2]
Overview
Cysticercosis must be differentiated from other diseases that cause brain cystic lesions (as brain abscess and brain tumors) or ocular lesions (as retinal detachment and coats disease).
Differentiating cysticercosis from other diseases
Disease | Prominent clinical features | Lab findings | Radiological findings |
---|---|---|---|
Neurocysticercosis |
|
|
|
Brain abscess |
|
|
|
Brain tumors |
|
| |
Brain tuberculoma |
|
|
|
Neurosarcoidosis |
|
|
|
Disease | Prominent clinical feature | Radiological findings |
---|---|---|
Ocular cysticercosis | ||
Coats disease |
|
|
Retinal detachment |
|
|
Hyperthyroid Ophthalmopathy |
|
|
Retinoblastoma |
|
|
References
- ↑ Brouwer MC, Tunkel AR, McKhann GM, van de Beek D (2014). "Brain abscess". N. Engl. J. Med. 371 (5): 447–56. doi:10.1056/NEJMra1301635. PMID 25075836.
- ↑ "Brain Abscess — NEJM".
- ↑ 3.0 3.1 "Primary Brain Tumors in Adults - American Family Physician".
- ↑ "The Journal of Association of Chest Physicians - Tuberculoma of the brain - A diagnostic dilemma: Magnetic resonance spectroscopy a new ray of hope : Download PDF".
- ↑ 5.0 5.1 "Neurosarcoidosis".
- ↑ 6.0 6.1 "How to Diagnose and Manage Coats' Disease".
- ↑ 7.0 7.1 "Management of retinal detachment: a guide for non-ophthalmologists".
- ↑ 8.0 8.1 "Thyroid Ophthalmopathy - EyeWiki".
- ↑ 9.0 9.1 "c.ymcdn.com".